期刊文献+

新疆维吾尔族和汉族女性乳腺癌患者钼靶X线表现与免疫组织化学指标表达差异 被引量:3

Differences of mammographic findings and immunohistochemical markers in Xinjiang Uygur and Han women with infiltrating ductal carcinoma of breast
原文传递
导出
摘要 目的比较新疆地区维吾尔族(维族)与汉族女性乳腺浸润性导管癌患者钼靶X线表现、免疫组织化学指标差异。方法 42例维族女性乳腺浸润性导管癌患者(维族组),122例汉族女性乳腺浸润性导管癌患者(汉族组),术前均行乳腺钼靶X线检查,并取手术切除组织标本检测雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)、人表皮生长因子受体-2(human epidermal growth factor receptor-2,HER-2)、细胞增殖核抗原Ki-67阳性表达。结果汉族组钼靶X线检出肿块68例,维族组检出28例;维族组肿块伴钙化比率(64.29%)明显高于汉族组(41.18%)(P<0.05);维族组HER-2、Ki-67阳性表达率(76.2%、95.2%)均高于汉族组(34.4%、72.1%)(P<0.05),ER、PR阳性表达率(76.2%、66.7%)与汉族组(62.3%、54.1%)比较差异无统计学意义(P>0.05);维族组钼靶X线表现为肿块伴钙化者HER-2、Ki-67阳性表达率(75.0%、76.9%)高于汉族组(25.0%、42.3%)(P<0.05),表现为单纯肿块者ER、PR阳性表达率(16.7%、15.0%)低于汉族组(73.9%、65.0%)(P<0.05);2组ER、PR、HER-2、Ki-67阳性表达率在肿块边缘有无毛刺、分叶上差异无统计学意义(P>0.05)。结论维、汉族女性乳腺浸润性导管癌患者HER-2、Ki-67表达存在差异,且维族钼靶X线表现肿块伴钙化者HER-2、Ki-67表达率高于汉族。 Objective To compare the differences of the mammographic features and immunohistochemical markers of infiltrating ductal carcinoma of breast(IDCB)between Uygur and Han women in Xinjiang.Methods Mammography was performed in 42 Uygur IDCB patients(Uygur group)and 122 Han IDCB patients(Han group)before operation,and the expressions of estrogen receptor(ER),progesterone receptor(PR),human epidermal growth factor receptor 2(HER-2)and Ki-67 were detected after operation.Results Mammography results showed masses in 68 patients in Han group and28 patients in Uygur group.The calcification rate of mass was significantly higher in Uygur group(64.29%)than that in Han group(41.18%)(P0.05).The positive rates of HER-2 and Ki-67 were significantly higher in Uygur group(76.2%,95.2%)than those in Han group(34.4%,72.1%)(P0.05),and there were no significant differences in the positive rates of ER and PR between Uygur group(76.2%,66.7%)and Han group(62.3%,54.1%)(P0.05).The positive rates of HER-2 and Ki-67 in patients with calcified mass were significantly higher in Uygur group(75.0%,76.9%)than those in Han group(25.0%,42.3%)(P0.05).The positive rates of ER and PR in patients with simple mass were significantly lover in Uygur group(16.7%,15.0%)than those in Han group(73.9%,65.0%)(P0.05).There were no significant differences in the positive rates of ER,PR,HER-2 and Ki-67 between the patients with and without defined-shape edges and lobulated tumor in both two groups(P0.05).Conclusion Both HER-2 and Ki-67 are expressed differently between Uygur and Han women with IDCB,and the positive rates of HER-2 and Ki-67 in patients with calcified mass are higher in Uygur patients than those in Han patients.
作者 李欣欣 姚娟 陈鹰 熊欣欣 李白艳 吕新胜 LI Xinxi;YAO Juan;CHEN Ying;XIONG Xinxin;LI Baiyan;LYU Xinsheng(Medical Imaging Center,Karamay Central Hospital,Karamay 834000,China)
出处 《中华实用诊断与治疗杂志》 2018年第11期1068-1070,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 国家自然科学基金(8166305)
关键词 乳腺浸润性导管癌 乳腺钼靶X线 雌激素受体 孕激素受体 人表皮生长因子受体-2 Ki-67 维吾尔族 汉族 infiltrating ductal carcinoma of breast mammography estrogen receptor progesterone receptor human epidermal growth factor receptor-2 Ki-67 Uygur Han
  • 相关文献

参考文献10

二级参考文献94

  • 1杨名添,戎铁华,黄植蕃,曾灿光,龙浩,傅剑华,林鹏,王欣,王思愚,王曦,唐军.可手术乳腺癌6263例临床分析[J].癌症,2005,24(3):327-331. 被引量:46
  • 2江泽飞,徐兵河,宋三泰,孙燕.乳腺癌内分泌治疗的基本共识[J].中华肿瘤杂志,2006,28(3):238-239. 被引量:48
  • 3丁锦辉,黄先国,于冰,孙国辉.新疆维吾尔族女性乳腺癌临床病理特点与预后分析[J].肿瘤研究与临床,2006,18(8):550-552. 被引量:17
  • 4付欣鸽,李锋,王振华,胡文浩,米开·热木,蒋金芳,李洪安,李丽,郑玉琴,沈西华,庞丽娟.新疆地区维吾尔族乳腺癌BRCA1基因突变分析[J].中华医学遗传学杂志,2007,24(3):341-344. 被引量:5
  • 5全国肿瘤防治研究办公室,卫生部卫生信息中心.中国试点市、县恶性肿瘤的发病与死亡(1993-1997).北京:中国医药科技出版社,2002.
  • 6Stewart BW,Kleihues P. World cancer report. IARC Press,Lyon,2003.
  • 7Althuis MD, Dozier JM, Anderson WF, et al. Global trends inbreast cancer incidence and mortality 197-1997. Int J Epidemiol,2005,34(2):405-412.
  • 8郝捷,赵平,陈万青.2011中国肿瘤登记年报.北京:军事医学科学出版社,2012.
  • 9陈竺.全国第三次死因回顾滿样调查报告.北京:中国协和医科大学出版社,2008.
  • 10Ferlay J,Shin HR,Bray F,et al. GLOBOCAN 2008 vl.2,CancerIncidence and Mortality Worldwide : IARC CancerBase No. 10[internet]. Lyon, France: International Agency for Research onCancer; 2010. Available from: http://glofiocan.iarc.fr,accessedon 30/10/2011.

共引文献331

同被引文献24

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部